Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Open-label Placebos”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Post-approval studies (Phase 4)Temporarily pausedNCT02655562
What this trial is testing

Fractional Concentration of Exhaled NO(FeNO) to Direct The Treatment of Sub-acute Cough

Who this might be right for
Coughing
Beijing Chao Yang Hospital 200
Testing effectiveness (Phase 2)Active Not RecruitingNCT03796962
What this trial is testing

Evaluate XEN1101 as Adjunctive Therapy in Focal Epilepsy

Who this might be right for
Focal Epilepsy
Xenon Pharmaceuticals Inc. 325
Very early researchWithdrawnNCT04883983
What this trial is testing

OLP to Manage Pain in TJA: A Feasibility Study

Who this might be right for
Opioid DependenceOpioid Abuse
University of Alabama at Birmingham
Testing effectiveness (Phase 2)Looking for participantsNCT05922878
What this trial is testing

Study of ALTO-300 in MDD

Who this might be right for
Major Depressive Disorder
Alto Neuroscience 321
Early research (Phase 1)Study completedNCT00793793
What this trial is testing

Safety, Antiviral Activity and PK of MRD of BI 201335 in Chronic Hepatitis C Patients Both Treatment Naive and -Experienced

Who this might be right for
Hepatitis C, Chronic
Boehringer Ingelheim 96
Not applicableTemporarily pausedNCT04245332
What this trial is testing

Effects of Fish Oil and Resistance Training on Muscle Mass and Function

Who this might be right for
Fat-free MasssMuscle StrengthNeuromuscular Function
Rowan University 20
Large-scale testing (Phase 3)Ended earlyNCT03041116
What this trial is testing

Efficacy and Safety Study of Fosmetpantotenate (RE-024) in PKAN Participants

Who this might be right for
Pantothenate Kinase-Associated Neurodegeneration
Travere Therapeutics, Inc. 84
Testing effectiveness (Phase 2)Ended earlyNCT03283826
What this trial is testing

Phase 1/2 Study to Evaluate the Safety and Efficacy of ATA188 in Subjects With Progressive Multiple Sclerosis

Who this might be right for
Primary Progressive Multiple SclerosisSecondary Progressive Multiple Sclerosis
Atara Biotherapeutics 134
Not applicableNot Yet RecruitingNCT06977594
What this trial is testing

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancer
Seoul National University Hospital 1,000
Not applicableStudy completedNCT02802241
What this trial is testing

Effects of Open-label vs Double-blind Treatment in IBS

Who this might be right for
Irritable Bowel SyndromePlacebo EffectPlacebos+1 more
Beth Israel Deaconess Medical Center 340
Large-scale testing (Phase 3)Study completedNCT01816295
What this trial is testing

A Study in Men With Low Testosterone to Measure the Effects of Testosterone Solution on Testosterone Levels, Sex Drive and Energy

Who this might be right for
Hypogonadism
Eli Lilly and Company 715
Testing effectiveness (Phase 2)Study completedNCT03625466
What this trial is testing

Explore the Impact of Lumacaftor/Ivacaftor on Disease Progression in Subjects Aged 2 Through 5 Years With Cystic Fibrosis, Homozygous for F508del

Who this might be right for
Cystic Fibrosis
Vertex Pharmaceuticals Incorporated 51
Testing effectiveness (Phase 2)Active Not RecruitingNCT07112872
What this trial is testing

Compare Different Doses of RO7795081 With a Placebo or Semaglutide in People With Type 2 Diabetes

Who this might be right for
Type 2 Diabetes Mellitus
Hoffmann-La Roche 240
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06732245
What this trial is testing

Safety and Efficacy of NA-931 and Tirzepatide in Adults Who Are Overweight or Obese

Who this might be right for
Obesity and Overweight
Biomed Industries, Inc. 224
Large-scale testing (Phase 3)Active Not RecruitingNCT06508021
What this trial is testing

Andecaliximab in Participants With Fibrodysplasia Ossificans Progressiva (FOP)

Who this might be right for
Fibrodysplasia Ossificans Progressiva
Ashibio Inc 92
Large-scale testing (Phase 3)Active Not RecruitingNCT04526665
What this trial is testing

Study of Elafibranor in Patients With Primary Biliary Cholangitis (PBC)

Who this might be right for
Primary Biliary Cirrhosis
Ipsen 161
Not applicableStudy completedNCT03626311
What this trial is testing

Omega-3 Replacement With Krill Oil in Disease Management of SLE

Who this might be right for
Systemic Lupus Erythematosus (SLE)
Aker BioMarine Human Ingredients AS 76
Testing effectiveness (Phase 2)Study completedNCT00328172
What this trial is testing

Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes Patients

Who this might be right for
Diabetes Mellitus, Type 2
Boehringer Ingelheim 302
Early research (Phase 1)Study completedNCT01369277
What this trial is testing

A Single Dose Study In Japanese And Western Healthy Subjects To Investigate The Safety, Tolerability And Pharmacokinetics Of PF-04991532

Who this might be right for
Diabetes MellitusDiabetes Mellitus, Type 2Glucose Metabolism Disorders
Pfizer 22
Testing effectiveness (Phase 2)Ended earlyNCT03919799
What this trial is testing

KD025 in Subjects With Diffuse Cutaneous Systemic Sclerosis

Who this might be right for
System; SclerosisDiffuse Cutaneous Systemic Sclerosis
Kadmon, a Sanofi Company 36
Next Page